BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Mechanisms/Insulin Signaling
MECHANISM
IRS

Natural Insulin Sensitisers — Evidence-Based Compounds

MECHANISM OVERVIEW

Insulin signalling through IRS-1/PI3K/Akt drives glucose uptake into cells — its dysregulation underlies type 2 diabetes, metabolic syndrome, PCOS, and accelerated aging.

Insulin resistance — impaired cellular response to insulin signalling — is the metabolic dysfunction underlying type 2 diabetes, obesity, PCOS, and many cardiovascular conditions. Compounds that improve insulin sensitivity work through GLUT4 translocation, AMPK activation, PPAR-γ modulation, or reduction of inflammatory interference with IRS-1. The following are ranked by evidence from the BiohacksAI corpus.

Key Molecular Targets

Click a target to see all compounds with documented interactions in the BiohacksAI corpus.

Related Mechanisms

Rankings based on BiohacksAI discovery score, target match with INSR, IRS1, PIK3CA, pathway overlap, and PubMed study count. All data is deterministic and corpus-verified. Not medical advice.

All mechanisms · Browse all compounds · Biological pathways · Health conditions

Data: PubMed/NCBI, BindingDB, Reactome. © Organiq Sweden AB · Patent pending EVE-PAT-2026-001